Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 1101 - 1125 of 1181 in total

Tesetaxel

Tesetaxel has been used in trials studying the treatment of Cancer, Melanoma, Prostate Cancer, Gastric Carcinoma, and Advanced Melanoma, among others.
Investigational

BMS-777607

BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.
Investigational

Vidupiprant

Vidupiprant has been used in trials studying the treatment and basic science of Asthma.
Investigational

Defactinib

Defactinib has been investigated for the treatment of Malignant Pleural Mesothelioma.
Investigational

SAR-405838

SAR405838 has been used in trials studying the treatment of Neoplasm Malignant.
Investigational

HCV-086

HCV-086 is a small molecule antiviral designed to block an enzyme required for the replication of the hepatitis C virus.
Investigational

Nesbuvir

Nesbuvir has been investigated for the treatment of Hepatitis C.
Investigational

3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide

3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide is a solid. This compound belongs to the phenylmorpholines. These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or a CN bond. This drug targets mitogen-activated protein kinase 14.
Experimental

Solithromycin

Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections.
Investigational

Rociletinib

Rociletinib has been used in trials studying the treatment and prevention of Nonsmall Cell Lung Cancer, Non-small Cell Lung Cancer, and Locally Advanced or Metastatic Non-small Cell Lung Cancer.
Investigational

Zalypsis

Zalypsis has been used in trials studying the treatment of Lymphoma, Solid Tumors, Ewing's Sarcoma, Endometrial Cancer, and Uterine Cervical Cancer, among others.
Investigational

GS-9256

GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.
Investigational

Rufloxacin

Rufloxacin is a quinolone antibiotic.
Experimental

Eribaxaban

Experimental

D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide

Experimental

Andarine

Andarine is a non-steroidal selective androgen receptor modulator.
Experimental

4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid

Experimental

1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide

Experimental

N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA

Experimental

N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE

Experimental

1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE

Experimental

Marbofloxacin

Marbofloxacin is a carboxylic acid, part of the third generation of antibiotic fluoroquinolones. It is used in veterinary medicine. A formulation of marbofloxacin combined with clotrimazole and dexamethasone is available under the name Aurizon.
Vet approved

Orbifloxacin

Orbifloxacin is a fluoroquinolone antibiotic. It is marketed by Schering-Plough Animal Health and approved for certain infections in dogs.
Vet approved

LY-3039478

LY3039478 has been used in trials studying the treatment and basic science of LYMPHOMA, Neoplasms, Solid Tumor, COLON CANCER, and BREAST CANCER, among others.
Investigational

HKI-357

Hki 357 is under investigation in clinical trial NCT00550381 (Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects).
Investigational
Displaying drugs 1101 - 1125 of 1181 in total